The present disclosure is directed to tetrahydroquinazoline derivatives of Formula I and their use for selectively killing HIV infected GAG-POL expressing cells without concomitant cytotoxicity to HIV naïve cells, and for the treatment or prophylaxis of infection by HIV, or for the treatment, prophylaxis or delay in the onset or progression of AIDS or AIDS Related Complex (ARC).
本公开涉及公式I的四氢喹噁啉衍
生物及其用于选择性杀灭HIV感染的GAG-POL表达细胞,而不对HIV天然细胞产生细胞毒性,以及用于治疗或预防HIV感染,或用于治疗、预防或延缓艾滋病或艾滋病相关综合征(ARC)的发病或进展。